Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
CPT Code

CPT code 64680 – Neurolytic celiac plexus block


Code Definition

64680 is the CPT code for destruction by neurolytic agent, with or without radiologic monitoring; celiac plexus.

Pain management physicians, interventional radiologists, and anesthesiologists report it when they permanently ablate the celiac nerve network with alcohol or phenol. The usual goal is control of severe visceral pain from pancreatic cancer or intractable chronic pancreatitis. Imaging guidance is included in the code, and payers audit neurolytic procedures, so the operative note must name the agent and the indication.

Section
10004-69990 Surgery
Subsection
61000-64999 Nervous system
Code range
64600-64681 Destruction by neurolytic agent (eg, chemical, thermal, electrical or radiofrequency), chemodenervation
Billable
No
Code also known as
celiac plexus neurolysis, chemical celiac block, celiac ganglion ablation, neurolytic celiac block
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

CPT 64680 describes permanent chemical ablation of the celiac plexus, distinct from the temporary anesthetic block reported with CPT 64530.

Radiologic monitoring is included in 64680, so CT, fluoroscopic or ultrasound guidance is never reported as a separate code.

Modifier 50 (bilateral) almost never applies, because the celiac plexus is a midline structure, not a paired nerve.

EUS-guided celiac neurolysis is an endoscopic procedure reported with CPT 43253, not 64680.

Pabau’s claims management software tracks prior authorization on the case and submits 64680 claims through Claim.MD, with eligibility checks and ERA remittances alongside.

CPT Code 64680: Official descriptor and code category

CPT Code 64680 reports destruction of the celiac plexus with a neurolytic agent, such as absolute alcohol or phenol, with or without radiologic monitoring. The code belongs to the AMA’s CPT code set, in the Surgery section’s Nervous System range 64600-64681. That range covers destruction by neurolytic agent and chemodenervation, and the AMA publishes the full descriptor as follows.

Official descriptor: “Destruction by neurolytic agent, with or without radiologic monitoring; celiac plexus.”

The key phrase here is “destruction by neurolytic agent.” This wording sets 64680 apart from anesthetic or steroid blocks, because those only last a short time. A neurolytic agent, usually absolute alcohol or phenol, chemically ablates the nerve tissue. As a result, pain signals stop reaching the brain for the long term.

FieldDetail
CPT code64680
Official descriptorDestruction by neurolytic agent, with or without radiologic monitoring; celiac plexus
CPT sectionSurgery / Nervous System / Neurolysis
Code family64600-64681 (Destruction by Neurolytic Agent)
Target nerve structureCeliac plexus (solar plexus / celiac ganglion)
EffectPermanent (destructive), not temporary
Common agentsAbsolute alcohol, phenol

What procedures does CPT 64680 cover?

CPT 64680 covers celiac plexus neurolysis, the injection of a neurolytic agent into or around the celiac plexus. In practice, the agent ablates the nerve network that carries visceral pain from the upper abdominal organs. Also, the celiac plexus lies behind the abdominal lining at the T12-L1 vertebrae, in front of the aorta.

The code also reports the percutaneous approach, the injection of the neurolytic agent, and any imaging guidance used to place the needle. Endoscopic ultrasound (EUS)-guided celiac neurolysis is a different procedure, reported with the endoscopic code 43253 rather than 64680. Primary clinical indications include:

  • Pancreatic malignancy with severe upper abdominal pain
  • Upper abdominal malignancies (gastric, hepatic, biliary)
  • Intractable chronic pancreatitis where conservative therapy has failed
  • Severe visceral pain refractory to pharmacologic management

Radiologic monitoring is included in 64680

However, radiologic monitoring is always bundled into CPT 64680. The descriptor reads “with or without radiologic monitoring”, so CT, fluoroscopic or ultrasound guidance used to place the needle is part of the code.

For that reason, do not add a guidance code such as 77002, 77003, 77012 or 76942 to a 64680 claim. Medicare’s NCCI edits treat that guidance as part of the procedure. Reporting it separately is therefore an unbundling error that draws post-payment audits.

CPT 64680 vs. CPT 64530: Which code is correct?

CPT 64530 covers injection of an anesthetic or steroid agent into the celiac plexus for a diagnostic or temporary therapeutic purpose. By contrast, CPT 64680 covers permanent chemical destruction of that same structure. The clinical difference is permanent vs. temporary effect. Reporting both on the same date of service is an unbundling error under NCCI editing logic. That is because the neurolytic procedure (64680) subsumes any diagnostic injection.

FeatureCPT 64680CPT 64530
Procedure typeNeurolytic (destructive)Anesthetic / steroid injection
Duration of effectPermanent (or long-term)Temporary (days to weeks)
Agent usedAlcohol or phenolLocal anesthetic or corticosteroid
Primary indicationCancer pain, intractable pancreatitisDiagnostic block, short-term relief
Bill both same DOS?No – 64680 subsumes 64530No – unbundling error
Prior auth frequencyOften required (commercial, MA)Less common

A physician may perform a diagnostic celiac block to confirm pain response, then proceed straight to neurolysis in the same session. As a result, only CPT 64680 is reported. Likewise, National Correct Coding Initiative (NCCI) guidance does not let you bill the diagnostic part on its own at that visit.

The route matters as much as the agent, so the decision flow below asks about both before it lands on a code.

Decision flow for celiac plexus coding: endoscopic ultrasound route is CPT 43253
Ask about the route first, because an EUS-guided injection leaves the 64600-64681 range entirely. Codes follow the AMA CPT descriptors and NCCI bundling guidance.

Several codes often appear with, or get confused with, CPT Code 64680 in pain management and interventional radiology billing.

CPT codeShort descriptorKey distinction from 64680
64530Injection, anesthetic agent; celiac plexusTemporary anesthetic/steroid, not neurolytic
64612Chemodenervation of muscle(s); muscle(s) innervated by facial nerve, unilateralDifferent nerve structure; chemodenervation, not plexus ablation
64483Injection, anesthetic agent and/or steroid, transforaminal epiduralSpinal/epidural route, not celiac plexus
64681Destruction by neurolytic agent; superior hypogastric plexusPelvic plexus, not celiac; different anatomy

Transforaminal epidural injections such as 64483 treat radicular spine pain, so they never stand in for a plexus code. Also, the 64681 superior hypogastric code is the usual mix-up for pelvic cancer pain.

ICD-10 diagnosis codes to pair with CPT 64680

Payers require a diagnosis code that justifies neurolytic (not merely anesthetic) intervention, because the effect is permanent. The ICD-10-CM codes most often accepted with CPT 64680 reflect malignant disease, intractable pancreatitis, or severe chronic pain that has not responded to conservative care. For example, using a vague diagnosis code, such as unspecified abdominal pain without prior treatment documentation, is a common medical necessity denial trigger.

ICD-10-CM codeClinical descriptionNotes for 64680 billing
C25.0Malignant neoplasm of head of pancreasMost common indication; strongest medical necessity support
C25.9Malignant neoplasm of pancreas, unspecifiedAcceptable when site not documented; specify if possible
K86.1Other chronic pancreatitisRequires documentation of failed conservative therapy
G89.29Other chronic painAcceptable as secondary code alongside a primary malignancy code
R10.9Unspecified abdominal painUse only when no more specific code available; high denial risk alone
C22.0Hepatocellular carcinomaAcceptable for upper abdominal malignancy with visceral pain

Always list the most specific diagnosis code available as the primary code. If R10.9 or G89.29 is the standalone primary diagnosis, it will likely trigger a medical necessity review or denial.

Medicare reimbursement and RVU values for CPT 64680

Medicare pays CPT 64680 at the code’s total Relative Value Units (RVUs) times the annual conversion factor set by CMS. Facility and non-facility payment differ because the practice expense (PE) RVU is lower in a hospital or ASC. Instead, the facility bills for overhead on its own in those settings.

Use the FastRVU lookup tool to find the current work, practice expense, and malpractice RVU parts for 64680, since they vary by region. Payment amounts change each January when CMS updates the conversion factor and geographic practice cost index (GPCI) values. Verify current figures rather than relying on prior-year rates.

Workers’ compensation carriers usually pay at or above the Medicare fee schedule rate, although state fee schedule rules apply. Commercial payers negotiate their own rates, which often exceed Medicare but vary widely by plan. Always verify the contracted rate in your payer agreement before estimating reimbursement.

CPT modifiers for code 64680

Applying the wrong modifier to CPT Code 64680 often causes claim rejection, so use the table below. The table below covers the modifiers most applicable to celiac plexus neurolysis, including one that is often misapplied.

ModifierNameUse with CPT 64680?Notes
50Bilateral procedureRarely, if everThe celiac plexus is a midline structure, not bilateral. Modifier 50 is almost never right for 64680 and will trigger payer review.
LT / RTLeft side / right sideUsually not applicableSame reason as modifier 50. The celiac plexus is midline. Applying LT or RT implies a side that does not exist in the body.
59Distinct procedural serviceYes, when it appliesUse when 64680 is performed alongside another procedure at the same encounter and there is a valid reason to bypass an NCCI bundling edit. Document the distinct indication clearly.
76Repeat procedure by same physicianYes, when it appliesUse when the neurolytic block is repeated at a later encounter by the same treating provider. Document the clinical reason for repeat treatment.
77Repeat procedure by different physicianYes, when it appliesUse when a different physician repeats the procedure. Same documentation requirements as modifier 76.

The modifier 50 trap: Some celiac plexus neurolysis claims carry modifier 50 because the physician placed two needles. A bilateral paravertebral technique still ablates one structure, since the celiac plexus is a single midline network of ganglia.

As a result, payers often deny or question modifier 50 on this code. Report 64680 once, without the modifier, and the rejection never happens.

Documentation requirements for medical necessity

Payers audit neurolytic procedures, so incomplete documentation is a common reason CPT Code 64680 claims are denied on post-payment review. The operative report and supporting chart notes must contain each of the following elements before submission.

  • Diagnosis with specificity: The documented diagnosis must justify permanent ablation, not merely diagnostic or temporary intervention. For example, cite the cancer staging or confirmed pancreatitis.
  • Failed conservative therapy: Chart notes must show that less invasive options (medication, prior anesthetic blocks) were tried first, but they did not work well enough.
  • Neurolytic agent identified: The operative report must name the agent used (e.g. “10 mL absolute ethanol”), and it must also give the volume injected.
  • Needle placement confirmation: When imaging guidance was used, keep the saved images or a note confirming needle placement in the operative record. If guidance was not used, document the approach and technique for unguided access.
  • Post-procedure note: Document the patient’s response, any early complications, and the clinical plan. This also completes the medical necessity loop for payer review.

Prior authorization requirements

Most commercial payers and many Medicare Advantage plans require prior authorization for CPT 64680 before the procedure is performed. Standard criteria include:

  • A confirmed malignancy or intractable pain diagnosis
  • Documentation of failed prior therapy
  • In some plans, a performing provider who is a credentialed anesthesiologist, interventional radiologist, or pain management specialist

Understanding medical billing fundamentals for high-cost procedures is the starting point, but prior auth status tracking needs to happen at the practice level before scheduling. Failing to obtain authorization when a payer requires it is a denial that cannot be fixed with an appeal afterward in most cases.

Common claim denial reasons and how to avoid them

CPT 64680 has a fairly narrow denial pattern. If your practice bills this code often, you will meet one of the following denial triggers. Denial management workflows that catch these before submission cut the cost of appeals. Our guide to medical billing denial codes also explains the CARC and RARC codes each trigger returns.

Denial reasonTriggerPrevention strategy
Wrong code selection64530 billed when neurolytic agent was usedConfirm agent type in op report before coding: Anesthetic = 64530, neurolytic = 64680
Missing prior authorizationProcedure performed without payer approvalVerify auth requirements at insurance verification, before scheduling
Medical necessity not documentedOp report lacks failed-therapy history or diagnosis specificityUse a pre-procedure documentation checklist, and confirm all five elements above are present
Unbundling (64530 + 64680)Both codes billed on the same date of serviceReport only 64680 when neurolysis is performed; remove 64530 from the claim
Modifier error (modifier 50)Bilateral modifier applied to a midline structureRemove modifier 50, and document single-structure anatomy in clinical notes
Unbundled imaging guidance77002, 77003, 77012 or 76942 billed with 64680Remove the guidance code, because radiologic monitoring is included in 64680

How to document and bill CPT 64680 correctly

When you bill CPT Code 64680, a clean workflow moves through six steps. A clean claim that pays on the first pass skips the rework cycle of denials, corrections and appeals.

  1. Confirm procedure matches the 64680 descriptor. Review the operative note to confirm the agent was neurolytic (alcohol or phenol), not an anesthetic or steroid. If the agent was anesthetic, the correct code is 64530.
  2. Assign the most specific ICD-10-CM diagnosis. For example, use C25.x for pancreatic malignancy, K86.1 for chronic pancreatitis, or the relevant malignancy code for other upper abdominal cancers. Avoid R10.9 on its own, because it invites denial.
  3. Verify prior authorization status. Confirm that authorization is on file for the payer and that it covers CPT 64680 specifically, not just “celiac plexus block.”
  4. Document the neurolytic agent and guidance method. The operative report must name the agent, volume, approach, and whether imaging guidance was used, because the payer will look for all four. Guidance is included in 64680, so no separate radiology code goes on the claim.
  5. Apply modifiers only when warranted. Use modifier 59 when a distinct procedure happens at the same visit, and modifier 76 or 77 for a repeat procedure. Leave modifier 50 off, because the celiac plexus is a single midline structure.
  6. Submit electronically through a clearinghouse. A Claim.MD clearinghouse connection returns eligibility checks before the visit. After payment, ERA 835 remittance files carry the denial-reason detail for any line that did not pay.

Pro Tip

Run a three-point check before submitting a CPT 64680 claim. Confirm the operative report names a neurolytic agent rather than an anesthetic. Verify the prior auth on file covers neurolysis specifically, and confirm modifier 50 is not on the claim. These three steps catch the majority of avoidable 64680 denials before they reach the payer.

How Pabau keeps CPT 64680 claims on track

Many 64680 denials start before the procedure, with an authorization nobody recorded or a claim built from an incomplete operative note. Pabau, the practice management platform we build, keeps the authorization and the claim on the same patient case.

Its claims management software tracks the prior authorization code, dates and approved sessions on the case. It warns you when an authorization is missing before the appointment is booked. Claims go out through Claim.MD, and then eligibility checks and ERA remittances come back to the same record.

However, Pabau does not choose or pair diagnosis codes for you. Your coders still own code selection, while the system keeps the authorization, the submission and the payment trail in one place.

Pabau checkout screen showing a completed payment and an invoice
Pabau’s checkout splits an invoice between insurer and patient, so the balance a payer leaves on a 64680 claim gets collected at the desk.

Keep 64680 authorizations and claims on one case

Pabau’s claims management software tracks prior authorization on the patient case and submits claims through Claim.MD. Eligibility checks and ERA remittances land on the same record, so your team can follow each 64680 claim from approval to payment.

Pabau claims management dashboard

Conclusion

CPT 64680 pays for a single procedure, the percutaneous neurolytic injection of the celiac plexus, with guidance included. Code the route and the agent from the operative note, and then the choice between 64680, 64530 and 43253 settles itself.

The denials that remain are mostly avoidable before the patient arrives. Therefore, secure an authorization that names neurolysis, document failed conservative therapy, and keep modifier 50 and separate imaging codes off the claim. A practice that builds those checks into scheduling spends its billing hours posting payments instead of writing appeals.

Book a demo to see how Pabau tracks 64680 authorizations and claims for pain management practices.

Continue your research

Continue your research

Need to understand how clearinghouse submission works? Pabau’s Claim.MD clearinghouse guide explains how EDI claims are validated and submitted to over 4,000 US payers.

Confused by denial codes on your 835 remittance? Denial codes in medical billing breaks down CARC reason codes and what each one means for your 64680 appeals.

Billing the electronic claim format? The 837 file explained covers how CPT codes, ICD-10 pairings, and modifiers are structured in an 837P professional claim.

Frequently asked questions

What is CPT Code 64680?

CPT Code 64680 is the billing code for destruction by neurolytic agent of the celiac plexus, with or without radiologic monitoring. A physician uses it when permanently ablating the celiac nerve network with a chemical agent such as absolute alcohol or phenol. The goal is control of severe visceral pain, most often from pancreatic cancer or intractable chronic pancreatitis.

Can CPT codes 64680 and 64530 be billed together?

No. CPT 64680 and CPT 64530 should not be billed together on the same date of service. Per NCCI editing logic, 64680 (neurolytic destruction) subsumes any diagnostic or anesthetic injection component, so only 64680 is reported when neurolysis is performed. Billing both codes together is an unbundling error that will trigger payer denial or recoupment.

Does CPT 64680 include radiologic monitoring, or is it billed separately?

Radiologic monitoring is included in CPT 64680. The descriptor covers the procedure with or without radiologic monitoring, so CT, fluoroscopic or ultrasound guidance is not reported separately. Adding 77002, 77003, 77012 or 76942 to the claim is an unbundling error under NCCI edits.

What ICD-10 codes are accepted with CPT 64680?

The ICD-10-CM codes most often paired with CPT 64680 are C25.0 or C25.9 (pancreatic malignancy) and K86.1 (other chronic pancreatitis). G89.29 (other chronic pain) works as a secondary code, and C22.0 (hepatocellular carcinoma) covers another upper abdominal cancer. The diagnosis must justify permanent neurolytic intervention. R10.9 (unspecified abdominal pain) used as a standalone primary diagnosis carries a high denial risk.

Avatar photo
Despina Petrushevska
Content Writer

Despina Petrushevska is a content writer covering aesthetics, dermatology, and clinic operations, known for making detailed clinical concepts clear and engaging. Outside of work, she enjoys photography, weekend getaways, and finding inspiration in everyday experiences.
×